• OPEN AN ACCOUNT
Indian Indices
Sensex
76,132.81 -382.62
( -0.50%)
Global Indices
Nasdaq
53,423.66 -283.45
(-0.53%)
Dow Jones
7,737.34 -31.37
(-0.40%)
Hang Seng
66,225.50 1,204.56
(1.85%)
Nikkei 225
10,828.70 -2.82
(-0.03%)
Forex
USD-INR
94.48 -0.24
(-0.26%)
EUR-INR
109.71 0.00
(0.00%)
GBP-INR
127.63 -0.19
(-0.15%)
JPY-INR
0.60 0.01
(1.60%)

EQUITY - MARKET SCREENER

Oxygenta Pharmaceutical Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524636
INE102E01018
-11.5421201
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
200.38
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

ITC consolidated net profit declines 72.69% in the March 2026 quarter
May 21,2026
Net profit of ITC declined 72.69% to Rs 5387.97 crore in the quarter ended March 2026 as against Rs 19727.37 crore during the previous quarter ended March 2025. Sales declined 5.04% to Rs 17628.89 crore in the quarter ended March 2026 as against Rs 18565.05 crore during the previous quarter ended March 2025.

For the full year,net profit declined 40.46% to Rs 20689.47 crore in the year ended March 2026 as against Rs 34746.63 crore during the previous year ended March 2025. Sales rose 4.77% to Rs 78213.28 crore in the year ended March 2026 as against Rs 74653.32 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales17628.8918565.05 -5 78213.2874653.32 5
OPM %39.2835.12 -34.9334.80 -
PBDT7619.777247.15 5 30035.6228573.26 5
PBT7197.826836.12 5 28325.0926926.94 5
NP5387.9719727.37 -73 20689.4734746.63 -40